CN110801502A - Traditional Chinese medicine preparation for treating hyperplasia of mammary glands - Google Patents

Traditional Chinese medicine preparation for treating hyperplasia of mammary glands Download PDF

Info

Publication number
CN110801502A
CN110801502A CN201910621609.3A CN201910621609A CN110801502A CN 110801502 A CN110801502 A CN 110801502A CN 201910621609 A CN201910621609 A CN 201910621609A CN 110801502 A CN110801502 A CN 110801502A
Authority
CN
China
Prior art keywords
parts
root
mammary glands
traditional chinese
chinese medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910621609.3A
Other languages
Chinese (zh)
Inventor
孙海霞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201910621609.3A priority Critical patent/CN110801502A/en
Publication of CN110801502A publication Critical patent/CN110801502A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/076—Poria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/233—Bupleurum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236—Ligusticum (licorice-root)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284—Atractylodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/285—Aucklandia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286—Carthamus (distaff thistle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A61K36/346—Platycodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/69—Polygalaceae (Milkwort family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A61K36/725—Ziziphus, e.g. jujube
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides a traditional Chinese medicine preparation for treating hyperplasia of mammary glands, which comprises peach blossom, peach kernel, safflower, bitter orange, medicinal cyathula root, peony flower, bupleurum, platycodon root, szechuan lovage rhizome, largehead atractylodes rhizome, Indian buead, membranous milkvetch root, rosemary and other raw materials. The traditional Chinese medicine composition can directly reach the focus through the characterization of hyperplasia of mammary glands and the compatibility of the traditional Chinese medicinal materials of all components, and has the effect of radically treating diseases. Meanwhile, it has the characteristics of promoting blood circulation by removing blood stasis, softening and resolving hard mass, regulating qi-flowing for relieving pain, enriching blood and nourishing liver, regulating qi-flowing for regulating menstruation, strengthening spleen and nourishing heart and the like, and has certain curative effect on female dizziness, blurred vision, irregular menstruation or small amount, amenorrhea and dysmenorrheal, lassitude of limbs, sallow complexion, insomnia and the like.

Description

Traditional Chinese medicine preparation for treating hyperplasia of mammary glands
Technical Field
The invention relates to a Chinese medicinal preparation for treating mammary gland diseases, in particular to a Chinese medicinal preparation for treating hyperplasia of mammary glands.
Background
With the pace of modern life accelerating, the progress of industrialization, the quality of air, water and food decreasing, and the change of activity places and living environment, the change of the fertility concept of women, more and more women suffer from hyperplasia of mammary glands.
The hyperplasia of mammary glands is not a tumor and is not an inflammation, and from the histological point of view, the hyperplasia and the degeneration of mammary glands are closely related to endocrine disturbance, and are caused by unbalanced endocrine hormone metabolism, increased estrogen level, hyperproliferation and involution insufficiency of mammary glands, and after a period of time, the hyperproliferation mammary glands cannot be completely regressed to form hyperplasia of mammary glands. Generally, the hyperplasia of mammary glands does not attract attention in the initial stage, when the symptoms are serious, the patient firstly thinks of western medicine treatment, and western medicines can only relieve the symptoms and cannot fundamentally treat the symptoms. The traditional Chinese medicine decoction is time-consuming and labor-consuming, and most patients cannot insist on the decoction for a long time.
At present, aiming at the treatment of hyperplasia of mammary glands, experts in the field of traditional Chinese medicine have proposed a plurality of traditional Chinese medicine material proportioning schemes, most of the traditional Chinese medicine materials are prepared from Chinese angelica, radix bupleuri, snakegourd fruit, ligusticum wallichii, cowherb seed, liquorice and the like, and decoction is carried out to obtain liquid medicine to treat hyperplasia of mammary glands.
Disclosure of Invention
The invention provides a Chinese medicinal preparation for treating hyperplasia of mammary glands, which can directly reach a focus through the compatibility of Chinese medicinal materials of all components through the representation of hyperplasia of mammary glands symptoms, and has the effect of radically treating diseases. Meanwhile, the traditional Chinese medicinal materials are prepared into preparations which are convenient to take and carry, and the preparation is beneficial to taking of patients.
The invention adopts the following technical scheme for realizing the aim:
a traditional Chinese medicine preparation for treating hyperplasia of mammary glands comprises the following raw materials:
peach blossom, peach kernel, safflower, bitter orange, medicinal cyathula root, peony flower, bupleurum root, platycodon root, Szechuan lovage rhizome, largehead atractylodes rhizome, Indian buead, astragalus root, rosemary, thinleaf milkwort root-bark, dried longan pulp, spina date seed, ginseng, costustoot, honey-fried licorice root, dried ginger, mint, szechwan chinaberry fruit, vinegar-processed rhizoma corydalis and chitin.
A traditional Chinese medicine preparation for treating hyperplasia of mammary glands comprises the following raw materials in parts by weight:
30-40 parts of peach blossom, 15-25 parts of peach kernel, 40-50 parts of safflower, 30-40 parts of bitter orange, 40-50 parts of medicinal cyathula root, 40-50 parts of peony flower, 15-25 parts of Chinese thorowax root, 30-40 parts of platycodon root, 40-50 parts of szechuan lovage rhizome, 70-80 parts of largehead atractylodes rhizome, 90-100 parts of Indian buead, 70-80 parts of membranous milkvetch root, 20-30 parts of rosemary, 70-80 parts of thinleaf milkwort root-bark, 70-80 parts of dried longan pulp, 90-100 parts of spina date seed, 15-25 parts of ginseng, 30-40 parts of costustoot, 30-40 parts of honey-fried licorice root, 10-20 parts of dried ginger, 40-50 parts of mint, 30-40 parts of szechwan.
Further, the preferred raw material ratio of the traditional Chinese medicine preparation for treating hyperplasia of mammary glands is as follows:
30 parts of peach blossom, 15 parts of peach kernel, 40 parts of safflower, 30 parts of bitter orange, 40 parts of medicinal cyathula root, 40 parts of peony flower, 15 parts of Chinese thorowax root, 30 parts of platycodon root, 40 parts of szechuan lovage rhizome, 70 parts of largehead atractylodes rhizome, 90 parts of Indian buead, 70 parts of membranous milkvetch root, 20 parts of rosemary, 70 parts of thinleaf milkwort root-bark, 70 parts of dried longan pulp, 90 parts of spina date seed, 15 parts of ginseng, 30 parts of costustoot, 30 parts of honey-fried licorice root, 10 parts of dried ginger, 40 parts of mint, 30.
A Chinese medicinal preparation for treating hyperplasia of mammary glands is prepared by weighing the above raw materials at a certain ratio, and making into tablet or capsule.
A Chinese medicinal preparation for treating hyperplasia of mammary glands is prepared by weighing the above raw materials at a certain ratio, mixing, dry grinding to obtain micropowder of 200 meshes or more, sterilizing, and filling into No. 0 capsule, wherein 0.5g micropowder is filled into each No. 0 capsule.
A preparation method of a traditional Chinese medicine preparation for treating hyperplasia of mammary glands comprises the steps of weighing the raw materials according to a ratio, uniformly mixing, carrying out dry grinding to obtain micro powder with the size of more than or equal to 200 meshes, adding edible starch and xylitol into the micro powder, and pressing into tablets, wherein the mass ratio of the micro powder to the edible starch to the micro powder to the xylitol is 10: 1.
The efficacy and compatibility of the raw materials in the formula are as follows:
peach blossom, flower of peach of Rosaceae. Bitter and neutral in nature. Relax bowels with purgative, induce diuresis to alleviate edema. Can be used for treating edema, ascites, and constipation. Also has effects of removing blood stasis and removing toxic substances.
Peach kernel, semen Persicae is sweet and neutral in nature and bitter in taste, enters lung, liver and large intestine meridians; has effects of removing blood stasis, moistening dryness and smoothing intestine; it is used to treat amenorrhea, dysmenorrhea, abdominal mass, traumatic injury, constipation due to intestinal dryness. In the formula, peach kernel and safflower are compatible, and peach kernel enters blood system, breaks blood and removes stasis, moistens and greasiness, moistens dryness and smoothes intestines; safflower promotes blood circulation, stimulates the menstrual flow, removes blood stasis and relieves pain. Peach kernel has strong blood stasis-breaking ability, safflower has red color and superior blood-moving ability. The two medicines are compatible and mutually promoted, activate blood and dredge channels, remove stasis and promote tissue regeneration, and enhance the efficacy of detumescence and pain relief.
Carthami flos has effects of promoting blood circulation, dredging channels, removing blood stasis, and relieving pain. Can be used for treating amenorrhea due to blood stagnation, dysmenorrhea, puerperal abdominal pain due to blood stasis, abdominal mass, thoracic obstruction, cardialgia, abdominal pain due to blood stasis, hypochondriac pain, traumatic injury, swelling and pain due to blood stasis, and macula due to blood stasis. It is combined with Tao ren, in addition, it can be used with Tao ren, Chuan Xiong and niu xi to treat abdominal pain due to stasis, and with Tao ren, chai Hu and Da Huang to treat stabbing pain in hypochondrium.
Fructus Aurantii is a nearly ripe fruit of Citrus aurantium L.of Rutaceae and its cultivar. Has the effects of regulating qi, relieving chest stuffiness, activating stagnancy and removing food retention. It can be used for treating fullness and distention of the chest and diaphragm, distending pain of hypochondrium, dyspepsia, abdominal distention, diarrhea, proctoptosis, and metroptosis. It is combined with Jie Geng to ascend and descend to relieve qi stagnation in chest.
Radix Cyathulae is the dried root of Cyathula officinalis of Amaranthaceae. Has the effects of promoting blood circulation, removing blood stasis, dispelling pathogenic wind, and promoting diuresis. Can be used for treating amenorrhea due to blood stasis, dystocia, retained afterbirth, puerperal abdominal pain due to blood stasis, heat stranguria, stranguria with stone, dysmenorrhea, rheumatism, lumbago, gonalgia, and traumatic injury. It is combined with Dang Gui, Chuan Xiong and hong Hua to play the actions of activating blood, inducing menstruation and alleviating pain.
Paeonia lactiflora (flower of Paeonia lactiflora (L.) pall. of Ranunculaceae) with bud as medicine. It is used for dredging channels and promoting blood circulation. It can be used for treating amenorrhea, dry blood tuberculosis, and leucorrhea with red and white discharge. It has effects in regulating female endocrine, removing yellow gas and color spot, and caring skin.
Bupleuri radix is dried root of Bupleurum scorzonerifolium or Bupleurum scorzonerifolium of Umbelliferae. Has the effects of relieving exterior syndrome, relieving fever, dispersing stagnated liver qi, relieving qi stagnation, and invigorating yang qi. It is mainly used for treating exterior syndrome fever, shaoyang syndrome, liver depression and qi stagnation, qi deficiency sinking, organ prolapse, fever abatement and malaria interception. It can be used together with rhizoma Cyperi, rhizoma Ligustici Chuanxiong, and radix Paeoniae alba for treating chest and hypochondrium or lower abdomen distending pain, depression, female menoxenia, dysmenorrhea, etc. due to liver qi stagnation.
Radix Platycodi is dried root of radix Platycodi of Campanulaceae. Collected in spring and autumn, cleaned, and then the fibrous root is removed, and the husk is stripped or not stripped when the fibrous root is fresh, and then dried. Growing in grass slopes, forest edges or in cultivation. Has effects of dispersing lung qi, relieving sore throat, eliminating phlegm, and expelling pus. Can be used for treating cough with excessive phlegm, chest distress, pharyngalgia, hoarseness, lung carbuncle, and purulent vomiting.
Rhizoma Ligustici Chuanxiong is dried rhizome of Umbelliferae plant rhizoma Ligustici Chuanxiong. Has effects of promoting blood circulation, activating qi-flowing, dispelling pathogenic wind and relieving pain. It can be used for treating pain due to blood stasis and qi stagnation, headache, and arthralgia due to wind-dampness. It is combined with Chi Shao and Tao ren to treat amenorrhea and dysmenorrhea due to blood stasis.
Bai Zhu is bitter and sweet in flavor and warm in nature. It enters spleen and stomach meridians. Invigorate spleen, replenish qi, dry dampness, induce diuresis, stop sweating, prevent abortion. Can be used for treating spleen deficiency, anorexia, abdominal distention, diarrhea, phlegm retention, dizziness, palpitation, edema, spontaneous perspiration, and threatened abortion. Tonify middle energizer and dry dampness, quench thirst and promote fluid production, benefit spleen essence, nourish stomach qi, descend turbid yin to eat and drink, relieve vomiting, ascend clear yang to digest food, and can purge and benefit. Mainly wind-cold-dampness arthralgia, spasm and jaundice, hidroschesis, heat removal and digestion promotion, and is used as a fried bait. Can be taken for a long time to reduce weight and prolong life without hunger.
Poria, a dry sclerotium of Poria cocos (Schw.) wolf, a fungus belonging to family Phellinaceae, often parasitizes on the root of pine tree, is in the shape of sweet potato, spherical, with light brown or dark brown outer skin, pink or white inner part, and is called white Poria cocos (Schw.) wolf or Poria cocos (Schw.) wolf after refining.
Astragalus root, radix astragali, sweet in flavor and slightly warm in nature, has the effects of invigorating qi, consolidating superficial resistance, promoting urination, strengthening heart, lowering blood pressure, resisting bacteria, expelling toxin, expelling pus, promoting granulation, enhancing capillary vessel resistance, arresting sweating and sex hormone, and can be used for treating exterior deficiency spontaneous perspiration, internal injury due to qi deficiency, spleen deficiency diarrhea, edema, carbuncle and cellulitis, etc.
Rosemary is the whole herb of Rosmarinus officinalis of Labiatae. Has effects of inducing perspiration, invigorating spleen, tranquilizing mind, and relieving pain. It can be used for treating headache and preventing alopecia. It can be used as menstruation-inducing medicine. It can accelerate menstruation due to hypomenorrhea or menopause caused by climacteric nervous disorder.
Yuan Zhi has bitter and pungent taste and warm property, and enters heart, kidney and lung meridians. Has the effects of soothing the nerves, promoting intelligence, eliminating phlegm and reducing swelling. Can be used for treating insomnia, dreaminess, amnesia, pavor, absentmindedness, expectoration, skin and external diseases, swelling and pain of breast caused by imbalance between heart-yang and kidney-yin. It is a good herb for restoring normal coordination between heart and kidney and tranquilizing mind, and can induce kidney-qi to strengthen spirit without forgetting.
The longan pulp has the effects of tonifying qi and enriching blood, and enhancing memory, the longan pulp contains abundant glucose, sucrose, protein and the like, has high iron content, and can improve heat energy, supplement nutrition and promote the regeneration of hemoglobin to enrich the blood. Can promote hemoglobin regeneration to treat palpitation, insomnia, and amnesia caused by anemia.
Zizyphi Spinosae semen, sweet in flavor, sour and neutral in flavor, enters heart, liver and gallbladder meridians. Has effects in nourishing heart, benefiting liver, tranquilizing mind, and arresting sweating. Has the effects of strengthening the middle-jiao, replenishing qi and strengthening the muscles and bones.
Ginseng, sweet; it is slightly bitter. It enters spleen, lung and heart meridians. Tonify primordial qi, recover pulse to stop collapse, tonify spleen and lung, promote the production of body fluid to quench thirst, induce tranquilization and promote intelligence. Consumptive disease due to overstrain, anorexia, listlessness, regurgitation, diarrhea, cough, dyspnea, spontaneous perspiration, palpitation, amnesia, vertigo, headache, sexual impotence, frequent micturition, diabetes, metrorrhagia, chronic infantile convulsion, and deficiency of qi, blood and body fluid
Radix aucklandiae is root of Compositae plant radix aucklandiae. Has effects of activating qi-flowing, relieving pain, regulating middle warmer, and removing food stagnation. It can be used for treating fullness and distention of chest and hypochondrium, abdominal pain, emesis, diarrhea, and dysentery with tenesmus. It is combined with ren Shen, Bai Zhu and Sha ren to tonify qi, strengthen middle energizer, regulate qi and harmonize stomach.
Prepared licorice root, radix Glycyrrhizae Praeparata, neutral in nature, sweet in flavor, enters twelve meridians. Has the pharmacological actions of detoxification, phlegm elimination, pain relief, spasmolysis and cancer resistance. In traditional Chinese medicine, liquorice tonifies spleen and qi, nourishes cough and moistens lung, relieves urgency and detoxifies, and regulates a plurality of medicines.
Gan Jiang is pungent, warm in nature and non-toxic. Ascending and yang. The usage is four: ban Xia has the action of removing toxicity, while Zao has the theory of thick intestine. Warming the meridians to dissipate the wind of exterior pathogen, benefiting qi and stopping the vomiturition of the stomach.
Mint, pungent in flavor and cool in nature. It enters lung and liver meridian, has effects of dispelling pathogenic wind heat, clearing and removing heat from throat, promoting eruption, removing toxic substance, dispersing stagnated liver qi, relieving qi stagnation and itching etc., is suitable for common cold with fever, headache, sore throat, anhidrosis, wind fire with red eyes, rubella, skin itch, hernia pain, dysentery and lymphoid tuberculosis etc., and has slight analgesic effect for external use, and is used for neuralgia etc.
Fructus Toosendan is dry mature fruit of Melia toosendan of Meliaceae. Has the functions of dispersing stagnated liver qi, clearing away heat, promoting qi circulation to arrest pain and killing parasite. It can be used for treating abdominal pain, hernia pain, abdominal pain due to parasitic infestation, and tinea capitis.
Vinegar-soaked rhizoma corydalis, warm; pungent and bitter; enter liver and spleen meridians, activate blood, promote qi circulation and alleviate pain. Can be used for treating pain in chest, hypochondrium, wrist and abdomen, amenorrhea, dysmenorrhea, puerperal blood stasis, traumatic injury, and swelling and pain.
Chitin, chitin and its various derivatives all have anti-infective action of different degrees, micromolecular chitin has excellent antitumor activity, especially chitin hexaglycan has very strong tumor-inhibiting action.
The invention adopts the technical scheme and has the following beneficial effects:
has the characteristics of promoting blood circulation by removing blood stasis, softening and resolving hard mass, regulating qi to alleviate pain, enriching blood and nourishing liver, regulating qi to regulate menstruation, strengthening spleen and nourishing heart and the like, and has good treatment effect on the female hyperplasia of mammary glands. Meanwhile, the traditional Chinese medicine composition has a certain treatment effect on female diseases such as dizziness, blurred vision, irregular or small amount of menstruation, amenorrhea, dysmenorrhea, lassitude of limbs, sallow complexion, insomnia and the like, is suitable for long-term administration by female adults, and has the effects of regulating internal secretion, maintaining beauty and keeping young.
Detailed Description
The present invention will be further described with reference to the following examples.
Example 1
1) Drying 30g of peach blossom, 15g of peach kernel, 40g of safflower, 30g of bitter orange, 40g of medicinal cyathula root, 40g of peony flower, 15g of Chinese thorowax root, 30g of platycodon root, 40g of szechuan lovage rhizome, 70g of largehead atractylodes rhizome, 90g of Indian buead, 70g of membranous milkvetch root, 20g of rosemary, 70g of thinleaf milkwort root-bark, 70g of dried longan pulp, 90g of spina date seed, 15g of ginseng, 30g of costustoot, 30g of honey-fried licorice root, 10g of dried ginger, 40g of mint, 30g of szechwan Chinaberr;
2) sterilizing the micro powder obtained in the step 1), and filling 0.5g of micro powder into a No. 0 capsule.
Example 2
1) Drying 30g of peach blossom, 15g of peach kernel, 40g of safflower, 30g of bitter orange, 40g of medicinal cyathula root, 40g of peony flower, 15g of Chinese thorowax root, 30g of platycodon root, 40g of szechuan lovage rhizome, 70g of largehead atractylodes rhizome, 90g of Indian buead, 70g of membranous milkvetch root, 20g of rosemary, 70g of thinleaf milkwort root-bark, 70g of dried longan pulp, 90g of spina date seed, 15g of ginseng, 30g of costustoot, 30g of honey-fried licorice root, 10g of dried ginger, 40g of mint, 30g of szechwan Chinaberr;
2) sterilizing the micro powder obtained in the step 1), and filling 0.5g of micro powder into a No. 0 capsule.
Example 3
1) Drying 30g of peach blossom, 15g of peach kernel, 40g of safflower, 30g of bitter orange, 40g of medicinal cyathula root, 40g of peony flower, 15g of Chinese thorowax root, 30g of platycodon root, 40g of szechuan lovage rhizome, 70g of largehead atractylodes rhizome, 90g of Indian buead, 70g of membranous milkvetch root, 20g of rosemary, 70g of thinleaf milkwort root-bark, 70g of dried longan pulp, 90g of spina date seed, 15g of ginseng, 30g of costustoot, 30g of honey-fried licorice root, 10g of dried ginger, 40g of mint, 30g of szechwan Chinaberr;
2) sterilizing the micro powder obtained in the step 1), adding 0.05g of edible starch and 0.05g of xylitol into 0.5g of micro powder, mixing uniformly, and tabletting.
Case 1
Zhao Yao hong, female, 32 years old. A dark face is more than half a year with distending pain in the breasts on both sides, three nodules on the left side, and two nodules on the right side. The tongue is purple-dark. A yellow and greasy coating and a deep and unsmooth pulse. The syndrome is due to blood stasis failing to nourish the face. The preparation of example 1 was administered 3 times a day, 5 tablets each time, and the symptoms were relieved after 10 days, and the treatment effect was satisfactory after 24 days.
Case 2
Gong Yu Fang, female, 45 years old. Self-complaints: the right breast pricks in the premenstrual period, affecting work and life, and the menstruation is slightly improved after menstruation is cleared. Dysphoria with smothery sensation in the chest, bitter taste and dry mouth. The amount of menstruation is large. Dark red, small clots. With pain in the lower abdomen and slight fevers in the palms and soles. The herbs are mostly treated by multi-side diagnosis and treatment, such as Long Dan Xiegan Tang, Rupixiao Xiao, Xiaoyao Wan, etc., with very little effect. The patient has a red tongue with petechia on the edge and a wiry, thready and rapid pulse. The syndrome is caused by stagnated heat in the liver meridian and blockage of the meridians. The agent of example 2 was administered 3 times daily for 5 tablets each time. Taken for 15 days. Stabbing pain during menstruation and abdominal pain are all the same. Follow-up 3 menses were not done.
Case 3
Zhaxiran, female, 38 years old. A tenesmus and distending pain of the two breasts for more than 3 years, tenderness, emotional irritation, overwork or heavy premenstrual pain. And (3) Western diagnosis: hyperplasia of mammary glands. Patients do not want surgery and require conservative treatment. The formulation of example 1 was administered. The medicine is taken 3 times a day, 5 tablets each time, and the curative effect is satisfactory after 30 tablets are taken.
Case 4
Xiao Li, female, age 32, not married. Distending pain of the left breast was accompanied by facial acne for 3 months. The distending pain is obviously worsened 1 week before menstruation. The pattern is due to blood stasis. The formulation of example 2 was administered. After 6 days, the symptoms are relieved, and the disease is cured after 1 month of administration.
Case 5
Wangting, female, 38 years old, insomnia for more than 3 years, chest distress, premenstrual bilateral breast stabbing pain, dizziness, headache, or poor sleep with disturbed dreams, 32429. The symptoms are a dark and lusterless complexion and listlessness. The tongue has ecchymosis, yellow and greasy coating, and wiry and unsmooth pulse. The pattern is due to stagnation of qi and blood. The formulation of example 3 was administered 3 times daily for 5 tablets each time. After 6 days, the symptoms are relieved, and after 20 days of taking, all symptoms disappear and are cured.

Claims (6)

1. A traditional Chinese medicine preparation for treating hyperplasia of mammary glands is characterized in that: the preparation method comprises the following raw materials: peach blossom, peach kernel, safflower, bitter orange, medicinal cyathula root, peony flower, bupleurum root, platycodon root, Szechuan lovage rhizome, largehead atractylodes rhizome, Indian buead, astragalus root, rosemary, thinleaf milkwort root-bark, dried longan pulp, spina date seed, ginseng, costustoot, honey-fried licorice root, dried ginger, mint, szechwan chinaberry fruit, vinegar-processed rhizoma corydalis and chitin.
2. The traditional Chinese medicine preparation for treating hyperplasia of mammary glands according to claim 1, wherein: the raw material ratio is as follows: 30-40 parts of peach blossom, 15-25 parts of peach kernel, 40-50 parts of safflower, 30-40 parts of bitter orange, 40-50 parts of medicinal cyathula root, 40-50 parts of peony flower, 15-25 parts of Chinese thorowax root, 30-40 parts of platycodon root, 40-50 parts of szechuan lovage rhizome, 70-80 parts of largehead atractylodes rhizome, 90-100 parts of Indian buead, 70-80 parts of membranous milkvetch root, 20-30 parts of rosemary, 70-80 parts of thinleaf milkwort root-bark, 70-80 parts of dried longan pulp, 90-100 parts of spina date seed, 15-25 parts of ginseng, 30-40 parts of costustoot, 30-40 parts of honey-fried licorice root, 10-20 parts of dried ginger, 40-50 parts of mint, 30-40 parts of szechwan.
3. The traditional Chinese medicine preparation for treating hyperplasia of mammary glands according to claim 2, wherein: the raw material ratio is as follows: 30 parts of peach blossom, 15 parts of peach kernel, 40 parts of safflower, 30 parts of bitter orange, 40 parts of medicinal cyathula root, 40 parts of peony flower, 15 parts of Chinese thorowax root, 30 parts of platycodon root, 40 parts of szechuan lovage rhizome, 70 parts of largehead atractylodes rhizome, 90 parts of Indian buead, 70 parts of membranous milkvetch root, 20 parts of rosemary, 70 parts of thinleaf milkwort root-bark, 70 parts of dried longan pulp, 90 parts of spina date seed, 15 parts of ginseng, 30 parts of costustoot, 30 parts of honey-fried licorice root, 10 parts of dried ginger, 40 parts of mint, 30.
4. A Chinese medicinal preparation for treating hyperplasia of mammary glands is prepared by weighing the above raw materials at a certain ratio, and making into tablet or capsule.
5. The traditional Chinese medicine preparation for treating hyperplasia of mammary glands according to claim 4, wherein: the preparation method comprises the steps of weighing the raw materials according to the proportion, uniformly mixing, carrying out dry grinding to prepare micropowder with the size of more than or equal to 200 meshes, sterilizing the prepared micropowder, filling the micropowder into No. 0 capsules, and filling 0.5g of micropowder into each No. 0 capsule.
6. The traditional Chinese medicine preparation for treating hyperplasia of mammary glands according to claim 4, wherein: the preparation method comprises the steps of weighing the raw materials according to the proportion, uniformly mixing, carrying out dry grinding to prepare micropowder with the size of more than or equal to 200 meshes, adding edible starch and xylitol into the micropowder and pressing into tablets, wherein the mass ratio of the micropowder to the edible starch to the micropowder to the xylitol is 10: 1.
CN201910621609.3A 2019-07-10 2019-07-10 Traditional Chinese medicine preparation for treating hyperplasia of mammary glands Pending CN110801502A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910621609.3A CN110801502A (en) 2019-07-10 2019-07-10 Traditional Chinese medicine preparation for treating hyperplasia of mammary glands

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910621609.3A CN110801502A (en) 2019-07-10 2019-07-10 Traditional Chinese medicine preparation for treating hyperplasia of mammary glands

Publications (1)

Publication Number Publication Date
CN110801502A true CN110801502A (en) 2020-02-18

Family

ID=69487375

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910621609.3A Pending CN110801502A (en) 2019-07-10 2019-07-10 Traditional Chinese medicine preparation for treating hyperplasia of mammary glands

Country Status (1)

Country Link
CN (1) CN110801502A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1824248A (en) * 2005-12-20 2006-08-30 付启荣 Capsule for treating proliferation of mammary gland and its production method
CN103127272A (en) * 2013-03-13 2013-06-05 云南郡筹制药有限公司 Chinese medicinal preparation for treating breast disease and preparation method thereof
CN106075325A (en) * 2016-08-29 2016-11-09 黄佩丽 For treating the medicine of qi stagnation type breast hyperplasia
CN109432178A (en) * 2018-12-04 2019-03-08 张为民 A kind of Chinese medicine composition and preparation method thereof for treating irregular menstruation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1824248A (en) * 2005-12-20 2006-08-30 付启荣 Capsule for treating proliferation of mammary gland and its production method
CN103127272A (en) * 2013-03-13 2013-06-05 云南郡筹制药有限公司 Chinese medicinal preparation for treating breast disease and preparation method thereof
CN106075325A (en) * 2016-08-29 2016-11-09 黄佩丽 For treating the medicine of qi stagnation type breast hyperplasia
CN109432178A (en) * 2018-12-04 2019-03-08 张为民 A kind of Chinese medicine composition and preparation method thereof for treating irregular menstruation

Similar Documents

Publication Publication Date Title
CN103316146B (en) Traditional Chinese medicinal preparation for anesthesia
CN104666579A (en) Traditional Chinese medicine composition for treating gonarthromeningitis and preparation method of traditional Chinese medicine composition
CN103432412A (en) Medicament for treating hyperplasia of mammary glands and preparation method thereof
CN103495103B (en) Medicament for promoting digestion and strengthening spleen
CN106309903A (en) Medicinal decoction for treating deafness and tinnitus and preparation method thereof
CN103212026B (en) A kind of Chinese medicine for the treatment of cholelithiasis and preparation method thereof and instructions of taking
CN110801502A (en) Traditional Chinese medicine preparation for treating hyperplasia of mammary glands
CN106924515B (en) Traditional Chinese medicine for treating explosive tinnitus and preparation method thereof
CN104800610A (en) Traditional Chinese medicine preparation for treating Parkinson's disease and preparation method thereof
CN104306583A (en) Traditional Chinese medicine composition for treating scanty menstruation and preparation method of traditional Chinese medicine composition
CN105709176A (en) Traditional Chinese medicine composition for treating heart blood stasis type palpitation and preparation method thereof
CN105998979A (en) Traditional Chinese medicine composition for treating lung-and-kidney-yin-deficiency-type chronic pharyngitis and method
CN104689093A (en) Medicine for treating proliferation of mammary gland
CN105998532A (en) Preparation method for traditional Chinese medicine for treating Qi-stagnancy and blood stasis painful heel and composition of traditional Chinese medicine
CN105999019A (en) Traditional Chinese medicine preparation for enhancing chemotherapeutic effect on breast cancer and preparation method of traditional Chinese medicine preparation
CN105055840A (en) Drug for treating arrhythmia and preparation method thereof
CN105031389A (en) Traditional Chinese medicine tablet for restraining malignant tumor breeding in cooperation with radiotherapy and preparing method of traditional Chinese medicine tablet
CN111558027A (en) Fumigating traditional Chinese medicine composition for postpartum rehabilitation
CN103860960A (en) Capsule for treating breast cancer and preparation method thereof
CN104706961A (en) Traditional Chinese medicine agent capable of moistening lung and clearing away heart-fire for patients with insomnia and dreaminess and preparation method of traditional Chinese medicine agent
CN104873854A (en) Traditional Chinese medicine preparation for rteriolar nephrosclerosis and preparation method thereof
CN104367954A (en) Traditional Chinese medicine decoction for treating angina
CN104707003B (en) The Chinese medicinal capsule for the treatment of hypertension, hyperlipidemia
CN105687362A (en) Blood-activating dysentery-relieving pill for treating chronic dysentery
CN104352872A (en) Traditional Chinese medicine for treating pulmonary asthenia due to deficiency heat

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20200218

WD01 Invention patent application deemed withdrawn after publication